Randomized controlled trial of acitretin versus placebo in patients at high‐risk for basal cell or squamous cell carcinoma of the skin (North Central Cancer Treatment Group … KC Kadakia, DL Barton, CL Loprinzi, JA Sloan, CC Otley, BB Diekmann, ... Cancer 118 (8), 2128-2137, 2012 | 96 | 2012 |
Supportive cryotherapy: a review from head to toe KC Kadakia, SA Rozell, AA Butala, CL Loprinzi Journal of pain and symptom management 47 (6), 1100-1115, 2014 | 77 | 2014 |
Patient-reported outcomes and early discontinuation in aromatase inhibitor-treated postmenopausal women with early stage breast cancer KC Kadakia, CF Snyder, KM Kidwell, NJ Seewald, DA Flockhart, ... The Oncologist 21 (5), 539-546, 2016 | 73 | 2016 |
Landscape of KRASG12C, Associated Genomic Alterations, and Interrelation With Immuno-Oncology Biomarkers in KRAS-Mutated Cancers ME Salem, SM El-Refai, W Sha, A Puccini, A Grothey, TJ George, ... JCO Precision Oncology 6, e2100245, 2022 | 57 | 2022 |
Fosaprepitant-induced phlebitis: a focus on patients receiving doxorubicin/cyclophosphamide therapy AD Leal, KC Kadakia, S Looker, C Hilger, K Sorgatz, K Anderson, ... Supportive Care in Cancer 22, 1313-1317, 2014 | 57 | 2014 |
Cancer patients' perceptions regarding the value of the physical examination: a survey study KC Kadakia, D Hui, GB Chisholm, SE Frisbee‐Hume, JL Williams, ... Cancer 120 (14), 2215-2221, 2014 | 33 | 2014 |
Palliative communications: addressing chemotherapy in patients with advanced cancer KC Kadakia, TJ Moynihan, TJ Smith, CL Loprinzi Annals of oncology 23, iii29-iii32, 2012 | 33 | 2012 |
Adjuvant endocrine therapy in premenopausal women with breast cancer KC Kadakia, NL Henry Clinical advances in hematology & oncology: H&O 13 (10), 663, 2015 | 31 | 2015 |
Malnutrition in cancer care: time to address the elephant in the room D Walsh, M Szafranski, A Aktas, KC Kadakia Journal of oncology practice 15 (7), 357-359, 2019 | 28 | 2019 |
Diffuse pulmonary lymphangiomatosis KC Kadakia, SM Patel, ES Yi, AH Limper Canadian respiratory journal 20, 52-54, 2013 | 28 | 2013 |
Comprehensive serial molecular profiling of an “N of 1” exceptional non-responder with metastatic prostate cancer progressing to small cell carcinoma on treatment KC Kadakia, SA Tomlins, SK Sanghvi, AK Cani, K Omata, DH Hovelson, ... Journal of hematology & oncology 8, 1-7, 2015 | 26 | 2015 |
Malnutrition risk at solid tumor diagnosis: the malnutrition screening tool in a large US cancer institute KC Kadakia, JT Symanowski, A Aktas, ML Szafranski, JC Salo, ... Supportive Care in Cancer, 1-8, 2022 | 22 | 2022 |
Current therapeutic targets in cancer cachexia: a pathophysiologic approach KC Kadakia, JM Hamilton-Reeves, VE Baracos American Society of Clinical Oncology Educational Book 43, e389942, 2023 | 21 | 2023 |
O-3 Characterization of KRAS mutation variants and prevalence of KRAS-G12C in gastrointestinal malignancies M Salem, S El-Refai, W Sha, A Grothey, A Puccini, T George, J Hwang, ... Annals of Oncology 32, S218, 2021 | 21 | 2021 |
Impact of sociodemographic disparities and insurance status on survival of patients with early-onset colorectal cancer ME Salem, A Puccini, SJ Trufan, W Sha, KC Kadakia, ML Hartley, ... The Oncologist 26 (10), e1730-e1741, 2021 | 20 | 2021 |
Antiemetic prescribing practices using a computerized physician order entry system KC Kadakia, AD Leal, DK Seisler, R Qin, KC Fee-Schroeder, ... Supportive Care in Cancer 22, 217-223, 2014 | 17 | 2014 |
Prospective assessment of patient-reported outcomes and estradiol and drug concentrations in patients experiencing toxicity from adjuvant aromatase inhibitors KC Kadakia, KM Kidwell, NJ Seewald, CF Snyder, AM Storniolo, JL Otte, ... Breast cancer research and treatment 164, 411-419, 2017 | 13 | 2017 |
Hot flashes: the ongoing search for effective interventions KC Kadakia, CL Loprinzi, DL Barton Menopause 19 (7), 719-721, 2012 | 13 | 2012 |
Factors influencing the use of extended adjuvant endocrine therapy KC Kadakia, KM Kidwell, DL Barton, AF Schott, DF Hayes, JJ Griggs, ... Breast Cancer Research and Treatment 175, 181-189, 2019 | 8 | 2019 |
Phase II evaluation of S-adenosyl-L-methionine (SAMe) for the treatment of hot flashes KC Kadakia, CL Loprinzi, PJ Atherton, KC Fee-Schroeder, A Sood, ... Supportive Care in Cancer 24, 1061-1069, 2016 | 7 | 2016 |